Wenzhou Li - Publications

Association of TPH2 polymorphisms with valproic acid efficacy and neurological adverse events in pediatric epilepsy.

Journal: Frontiers in pharmacology

Published: March 03, 2026

Advancing precision treatment in preterm infants: Population pharmacokinetics of caffeine for apnea of prematurity.

Journal: Drug metabolism and disposition: the biological fate of chemicals

Published: November 03, 2025

ABCC2 as a novel covariate influencing oxcarbazepine pharmacokinetics in pediatric epilepsy: Insights from population modeling.

Journal: Drug metabolism and disposition: the biological fate of chemicals

Published: February 19, 2025

Triglyceride-glucose index and prognosis in non-diabetic critically ill patients: data from the eICU database.

Journal: Frontiers in medicine

Published: January 21, 2025

A comprehensive review of caffeine population pharmacokinetics in preterm infants: Factors affecting clearance.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Published: November 05, 2024

Association study of ADORA2A gene polymorphisms with adverse drug reactions to valproic acid and oxcarbazepine in the treatment of children with epilepsy.

Journal: Epilepsia

Published: October 24, 2024

Population pharmacokinetic analysis for dose regimen optimization of vancomycin in Southern Chinese children.

Journal: CPT: pharmacometrics & systems pharmacology

Published: January 17, 2024

Association of ABCB1 Polymorphisms with Efficacy and Adverse Drug Reactions of Valproic Acid in Children with Epilepsy.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: September 12, 2023

Identification of novel SHANK2 variants in two Chinese families via exome and RNA sequencing.

Journal: Frontiers in neuroscience

Published: August 10, 2023

SCN1A Polymorphisms and Haplotypes Are Associated With Valproic Acid Treatment Outcomes in Chinese Children With Epilepsy.

Journal: Pediatric neurology

Published: December 07, 2022

Pharmacogenetics-based population pharmacokinetic analysis and dose optimization of valproic acid in Chinese southern children with epilepsy: Effect of ABCB1 gene polymorphism.

Journal: Frontiers in pharmacology

Published: September 05, 2022

Genetic Polymorphism of GABRG2 rs211037 is Associated with Drug Response and Adverse Drug Reactions to Valproic Acid in Chinese Southern Children with Epilepsy.

Journal: Pharmacogenomics and personalized medicine

Published: July 15, 2021